8 A prospective cohort study involving seven psoriasis patients with type 2 diabetes treated with liraglutide for 12 weeks observed a mean PASI decrease from 15.7 to 2.2 and a DLQI improvement from 21.8 to 4.1.9 Additionally, reductions in HbA1c, BMI, and waist circumference were observed.9 One randomized, placebo-controlled trial involving 20 obese, glucose-tolerant patients with plaque psoriasis, however, found no significant improvement in PASI after 8 weeks of liraglutide
doi: 10.1111/IJCP.13731 24 HepprichMZilligDFlorian-ReynosoMADonathMYRudofskyG
Talking with a dietitian
We believe in complete pricing transparency and will walk you through all costs during your initial consultation before you commit to anything
When you change from Mounjaro to Wegovy, it isnt simply about swapping one injection for another
Another key trend in the Liraglutide and Semaglutide Market Analysis is the increasing focus on cardiovascular benefits, impacting nearly 32% of treated patients with reduced risk of heart-related complications